Evidence map›Paper›PMID 26449484›Full record

ArticleGenome medicine2015

Many obesity-associated SNPs strongly associate with DNA methylation changes at proximal promoters and enhancers.

Sarah Voisin, Markus Sällman Almén, Galina Y Zheleznyakova, Lina Lundberg, Sanaz Zarei, Sandra Castillo, Fia Ence Eriksson, Emil K Nilsson, Matthias Blüher, Yvonne Böttcher and 4 more

Abstract read
In one paragraph

Article in Genome medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. AnResearch square · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sarah VoisinDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden. sarah.voisin.aeris@gmail.com.
Markus Sällman AlménDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden. markus.almen@imbim.uu.se.
Galina Y ZheleznyakovaDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden. galina.zheleznyakova@neuro.uu.se.
Lina LundbergDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden. lina.llundberg@gmail.com.
Sanaz ZareiDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden. sanaz.zr@gmail.com.
Sandra CastilloDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden. sandra.r.castillo@hotmail.se.
Fia Ence ErikssonDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden. fia.e@hotmail.com.
Emil K NilssonDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden. emil.nilsson@neuro.uu.se.
Matthias BlüherMedical Faculty, IFB Adiposity Diseases, University of Leipzig, Liebigstrasse 21, 04103, Leipzig, Germany. Matthias.Blueher@medizin.uni-leipzig.de.
Yvonne BöttcherMedical Faculty, IFB Adiposity Diseases, University of Leipzig, Liebigstrasse 21, 04103, Leipzig, Germany. Yvonne.Boettcher@medizin.uni-leipzig.de.
Peter KovacsMedical Faculty, IFB Adiposity Diseases, University of Leipzig, Liebigstrasse 21, 04103, Leipzig, Germany. peter.kovacs@medizin.uni-leipzig.de.
Janis KlovinsLatvian Biomedical Research and Study Center, Ratsupites 1, Riga, LV-1067, Latvia. klovins@biomed.lu.lv.
Mathias Rask-AndersenDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden. mathias.rask-andersen@neuro.uu.se.
Helgi B SchiöthDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden. Helgi.Schioth@neuro.uu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe mechanisms by which genetic variants, such as single nucleotide polymorphisms (SNPs), identified in genome-wide association studies act to influence body mass remain unknown for most of these SNPs, which continue to puzzle the scientific community. Recent evidence points to the epigenetic and chromatin states of the genome as having important roles.

methodsWe genotyped 355 healthy young individuals for 52 known obesity-associated SNPs and obtained DNA methylation levels in their blood using the Illumina 450 K BeadChip. Associations between alleles and methylation at proximal cytosine residues were tested using a linear model adjusted for age, sex, weight category, and a proxy for blood cell type counts. For replication in other tissues, we used two open-access datasets (skin fibroblasts, n = 62; four brain regions, n = 121-133) and an additional dataset in subcutaneous and visceral fat (n = 149).

resultsWe found that alleles at 28 of these obesity-associated SNPs associate with methylation levels at 107 proximal CpG sites. Out of 107 CpG sites, 38 are located in gene promoters, including genes strongly implicated in obesity (MIR148A, BDNF, PTPMT1, NR1H3, MGAT1, SCGB3A1, HOXC12, PMAIP1, PSIP1, RPS10-NUDT3, RPS10, SKOR1, MAP2K5, SIX5, AGRN, IMMP1L, ELP4, ITIH4, SEMA3G, POMC, ADCY3, SSPN, LGR4, TUFM, MIR4721, SULT1A1, SULT1A2, APOBR, CLN3, SPNS1, SH2B1, ATXN2L, and IL27). Interestingly, the associated SNPs are in known eQTLs for some of these genes. We also found that the 107 CpGs are enriched in enhancers in peripheral blood mononuclear cells. Finally, our results indicate that some of these associations are not blood-specific as we successfully replicated four associations in skin fibroblasts.

conclusionsOur results strongly suggest that many obesity-associated SNPs are associated with proximal gene regulation, which was reflected by association of obesity risk allele genotypes with differential DNA methylation. This study highlights the importance of DNA methylation and other chromatin marks as a way to understand the molecular basis of genetic variants associated with human diseases and traits.

Indexed as

DNA MethylationAdipose TissueAdolescentAdultAgedAllelesBrainCpG IslandsEnhancer Elements, GeneticFemaleFibroblastsHumansMaleMiddle AgedObesityPolymorphism, Single Nucleotide

Identifiers

PMID26449484
PMCPMC4599317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.